“…Consequently, mutations in α 2 δ genes are cause to neurological conditions such as ataxia (Calandre et al, 2016;Davies et al, 2007;Klugbauer et al, 2003), epilepsy (Faria et al, 2017;Celli et al, 2017;Dolphin, 2012;2013), and neuropathic pain (Chen et al, 2019;Nieto-Rostro et al, 2018, Bauer et al, 2009). However, despite numerous reports on the roles of α 2 δ subunits in HVA channel trafficking (Kadurin et al, 2017;Hendrich et al, 2008), surfacing (D'Arco et al, 2015;Cassidy et al 2014), and biophysical properties (Savalli et al, 2016;Davies et al, 2010, Felix et al, 1997, Hobom et al, 2000, Cantí et al, 2005, the specific in vivo functions that may result from different α 2 δ/α 1 combinations remain incompletely understood. In heterologous expression systems, full calcium current amplitudes require co-expression of α 2 δ and β with the pore forming HVA VGCC α 1 subunit (Barclay et al, 2001;Brodbeck et al, 2002;Davies et al, 2006;Cantí et al, 2005;Hoppa et al, 2012; for review see Dolphin, 2013), largely independent of which α 2 δ subunit is used, indicating redundant functions of α 2 δ subunits.…”